Page last updated: 2024-11-04
sulfinpyrazone and Calcium Pyrophosphate Deposition Disease
sulfinpyrazone has been researched along with Calcium Pyrophosphate Deposition Disease in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
McCarty, DJ | 1 |
Reviews
1 review available for sulfinpyrazone and Calcium Pyrophosphate Deposition Disease
Article | Year |
---|---|
Crystal deposition joint disease.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Colchicine; Crystallization; Diphosphates; Female; G | 1974 |